SkyePharma to cut back on manufacturing staff

pharmafile | March 11, 2009 | News story | Manufacturing and Production Europe, France, Skyepharma 

Related Content

EC approves combination treatment for kidney cancer

The European Commission (EC) has approved Ipsen’s Cabometyx in combination with Opdivo as a first-line …

PEP-Therapy and Institut Curie’s cancer drug trial approved in France

PEP-Therapy and Institut Curie have been granted approval from the French National Agency for Medicines …


Janssen’s esketamine nasal spray gets Europe approval for new indication

The European Commission (EC) has authorised the expanded use of Janssen’s Spravato (esketamine nasal spray), co-administered …

Latest content